Results 81 to 90 of about 6,539 (194)

Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome

open access: yesMiddle East Fertility Society Journal, 2017
Background: OHSS (Ovarian Hyperstimulation Syndrome) is the most serious iatrogenic complication of ovulation induction. The pathophysiology of OHSS is characterised by increased capillary permeability, leading to leakage of fluid from the vascular ...
Ahmed Samy Saad, Khalid Abd Aziz Mohamed
doaj   +1 more source

A Case of Heart Failure With Reduced Ejection Fraction Secondary to Dilated Cardiomyopathy due to Long‐Standing Untreated Acromegaly: A Case Report and Focused Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
Echocardiographic findings in dilated cardiomyopathy secondary to untreated acromegaly. (A) Apical four‐chamber view showing biventricular and biatrial dilation. (B‐C) Colour Doppler demonstrating mitral, aortic, and tricuspid regurgitation. (D) Reduced global longitudinal strain (GLS: −6.5%), consistent with severe systolic dysfunction.
Cristian Orlando Porras Bueno   +4 more
wiley   +1 more source

Pathogenesis of Adenomyosis: An Integrated Review of Cellular Origins, Molecular Mechanisms, and Intersecting Diseases

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 7, April 2026.
ABSTRACT Adenomyosis is a prevalent disorder of the archimetra, historically conflated with endometriosis but possessing a unique pathobiological trajectory. This review synthesises current molecular evidence to propose a unified mechanistic framework initiated by tissue injury and repair (TIAR), aberrant stem cell activation, or de novo metaplasia ...
Jiang Yang   +6 more
wiley   +1 more source

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study

open access: yesAvicenna Journal of Medicine, 2015
Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate
Niyazi Kilic   +5 more
doaj   +1 more source

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

open access: yesEquine Veterinary Education, Volume 38, Issue 3, Page e170-e179, March 2026.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess   +5 more
wiley   +1 more source

Long-term Effects of Cabergoline and Levodopa in Japanese Patients with Early Parkinson’s Disease: A 5-Year Prospective Study [PDF]

open access: yes
Several international studies have suggested that treatment of early Parkinsonʼs disease (PD) with a dopamine agonist instead of levodopa delays the occurrence of motor complications.
Utsumi, Hiroya   +1 more
core  

Iron molybdenum oxide-modified screen-printed electrode: Application for electrocatalytic oxidation of cabergoline [PDF]

open access: yes, 2020
This research designed a simplified, sensitive electro-chemical procedure to detect cabergoline by a means of a screen-priented electrode (SPE) modified with Fe2MoO6 magnetic nanocomposite (Fe2MoO6/SPE).
Van Le, Q.   +9 more
core  

The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma [PDF]

open access: yes, 2014
PubMedID: 23945126Prolactinomas are common pituitary tumors that can cause gonadal dysfunction and infertility related to hyperprolactinemia. Dopamine agonists are the first-line treatment in these patients.
Yüksel B.   +6 more
core   +1 more source

The treatment of prolactin microadenomas with cabergoline [PDF]

open access: yes, 2001
peer reviewedLa bromocriptine, un agoniste dopaminergique dérivé de l'ergot, a été mise au point peu de temps après la découverte de la prolactine et des prolactinomes vers 1970.
Beckers, Albert
core  

Stability of cabergoline in fox baits in laboratory and field conditions [PDF]

open access: yes, 2007
Cabergoline is a potent inhibitor of prolactin release and a potential fertility control agent for foxes. To understand how cabergoline could behave in baits deployed for fox control, we conducted laboratory and field trials to investigate the stability ...
Kirkwood, R (15510188)   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy